IAS Reports Third Quarter 2025 Financial Results

By PR Newswire | November 04, 2025, 7:35 AM

Total revenue increased 16% to $154.4 million

Net income of $7.0 million at a 5% margin; adjusted EBITDA increased to $55.3 million at a 36% margin 

NEW YORK, Nov. 4, 2025 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform, today announced financial results for the third quarter ended September 30, 2025.

"We exceeded our revenue and adjusted EBITDA outlook for the third quarter with strength across our businesses," said Lisa Utzschneider, CEO of IAS. "We are focused on working towards closing the previously announced acquisition of IAS by Novacap while advancing our business priorities."

Third Quarter 2025 Financial Highlights

  • Total revenue was $154.4 million, a 16% increase compared to $133.5 million in the prior-year period.
  • Optimization revenue was $73.7 million, a 21% increase compared to $61.1 million in the prior-year period.
  • Measurement revenue was $57.1 million, an 8% increase compared to $52.9 million in the prior-year period.
  • Publisher revenue was $23.5 million, a 21% increase compared to $19.5 million in the prior-year period.
  • International revenue, excluding the Americas, was $44.1 million, an 8% increase compared to $40.8 million in the prior-year period, or 29% of total revenue for the third quarter of 2025.
  • Gross profit was $118.8 million, a 12% increase compared to $106.2 million in the prior-year period. Gross profit margin was 77% for the third quarter of 2025.
  • Net income was $7.0 million, or $0.04 per share, compared to net income of $16.1 million, or $0.10 per share, in the prior-year period. Net income margin was 5% for the third quarter of 2025.
  • Adjusted EBITDA* was $55.3 million, a 9% increase compared to $50.6 million in the prior-year period. Adjusted EBITDA* margin was 36% for the third quarter of 2025.
  • Cash and cash equivalents were $129.2 million at September 30, 2025.

Recent Business Highlights

  • TMQ Expansion to Meta Threads – In October, IAS announced it is expanding Total Media Quality (TMQ) for Meta to bring third-party, independent Brand Safety & Suitability Measurement to Threads for the first time.
  • Brand Safety Measurement for TikTok Pangle – In October, IAS announced it was selected by TikTok to launch new Brand Safety Features, in addition to Viewability and Invalid Traffic Measurement, for advertisers on TikTok Pangle, the TikTok ad network for Business.
  • Measurement Expansion on Snap – In November, IAS announced the expansion of its measurement partnership with Snap to give advertisers greater tools to validate and optimize ad effectiveness to drive value for their campaigns across Snapchat.
  • Good-Loop Emissions Partnership – In September, IAS announced a significant step forward in the universal decarbonization of digital media, in partnership with responsible media platform Good-Loop. IAS is now enabling advertisers to directly and seamlessly measure emissions of every ad impression delivered across the open internet, at no additional cost.

Transaction with Novacap

On September 24, 2025, IAS announced that it entered into a definitive agreement to be acquired by Novacap, a leading North American private equity firm, in an all-cash transaction. Please refer to IAS's press release announcing the transaction for more information linked here. As a result of the announced transaction, IAS will not host a quarterly earnings conference call or provide a financial outlook. For further detail and discussion of IAS's financial performance, please refer to IAS's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed with the SEC.

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

(IN THOUSANDS, EXCEPT SHARE DATA)

September 30,

2025



December 31,

2024

ASSETS







Current assets:







Cash and cash equivalents

$      129,204



$        84,469

Restricted cash

294



506

Accounts receivable, net of allowance for credit losses of $3,845 and $7,454 as of September 30, 2025 and December 31, 2024, respectively

79,515



79,427

Unbilled receivables

54,093



53,388

Prepaid expenses and other current assets

54,093



36,639

Due from related party

13



28

Total current assets

317,212



254,457

Property and equipment, net

3,602



4,004

Internal use software, net

61,714



53,636

Intangible assets, net

115,631



140,943

Goodwill

677,635



673,025

Operating lease right-of-use assets, net

20,583



17,888

Deferred tax asset, net

2,439



1,675

Other long-term assets

9,002



5,943

Total assets

$   1,207,818



$   1,151,571

LIABILITIES AND STOCKHOLDERS' EQUITY







Current liabilities:







Accounts payable and accrued expenses

$        58,447



$        72,910

Operating lease liabilities, current

11,357



10,184

Due to related party

4



11

Deferred revenue

1,834



1,061

Total current liabilities

71,642



84,166

Deferred tax liability, net

8,991



3,118

Long-term debt, net



34,189

Operating lease liabilities, non-current

13,421



13,374

Other long-term liabilities

8,808



8,713

Total liabilities

102,862



143,560

Commitments and Contingencies







Stockholders' Equity







Preferred Stock, $0.001 par value, 50,000,000 shares authorized at September 30, 2025; 0 shares issued and outstanding at September 30, 2025 and December 31, 2024



Common Stock, $0.001 par value, 500,000,000 shares authorized, 166,863,690 and 162,871,266 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively

166



163

Additional paid-in-capital

1,025,055



964,765

Accumulated other comprehensive income (loss)

1,540



(3,666)

Retained earnings

78,195



46,749

Total stockholders' equity

1,104,956



1,008,011

Total liabilities and stockholders' equity

$   1,207,818



$   1,151,571

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(UNAUDITED)

 





Three Months Ended September 30,



Nine Months Ended September 30,

(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)



2025



2024



2025



2024

Revenue



$       154,358



$       133,528



$       437,628



$       377,063

Operating expenses:

















Cost of revenue



35,553



27,373



100,028



80,628

Sales and marketing



36,317



30,144



104,243



91,541

Technology and development



22,632



16,840



62,431



52,305

General and administrative



33,715



25,348



86,457



71,407

Depreciation and amortization



17,900



16,243



51,605



47,032

Foreign exchange loss (gain), net



667



(2,607)



(7,113)



(723)

Total operating expenses



146,784



113,341



397,651



342,190

Operating income



7,574



20,187



39,977



34,873

Interest income (expense), net



595



(1,325)



680



(4,787)

Net income before income taxes



8,169



18,862



40,657



30,086

Provision for income taxes



(1,124)



(2,773)



(9,211)



(7,562)

Net income



$           7,045



$         16,089



$         31,446



$         22,524

Net income per share – basic and diluted



$             0.04



$             0.10



$             0.19



$             0.14

Weighted average shares outstanding:

















Basic



166,473,735



161,663,506



165,056,742



160,528,610

Diluted



169,800,709



165,084,108



168,275,629



164,635,076

Other comprehensive income:

















Foreign currency translation adjustments



94



892



5,206



(360)

Total comprehensive income



$           7,139



$         16,981



$         36,652



$         22,164

 

Stock-Based Compensation 

(UNAUDITED)

 



Three Months Ended September 30,



Nine Months Ended September 30,

(IN THOUSANDS)

2025



2024



2025



2024

Cost of revenue

$                  82



$                  80



$                258



$                286

Sales and marketing

7,261



4,829



18,379



14,002

Technology and development

8,486



4,941



18,692



14,139

General and administrative

6,796



6,593



19,665



18,758

Total stock-based compensation

$            22,625



$            16,443



$            56,994



$            47,185

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(UNAUDITED)

 

Three Months Ended September 30, 2025

 





Common Stock

















(IN THOUSANDS, EXCEPT SHARES)



Shares



Amount



Additional

paid-in

capital



Accumulated

other

comprehensive

income



Retained

earnings



Total

stockholders'

equity

Balance, June 30, 2025



165,273,651



$               165



$    1,000,857



$            1,446



$         71,150



$    1,073,618

RSUs and MSUs vested



1,344,795



1









1

Option exercises



42,826





185







185

ESPP purchase



202,418





1,410







1,410

Stock-based compensation







22,603







22,603

Foreign currency translation adjustment









94





94

Net income











7,045



7,045

Balance, September 30, 2025



166,863,690



$               166



$    1,025,055



$            1,540



$         78,195



$    1,104,956















Nine Months Ended September 30, 2025

 

















Common Stock

















(IN THOUSANDS, EXCEPT SHARES)



Shares



Amount



Additional

paid-in

capital



Accumulated

other

comprehensive

income (loss)



Retained

earnings



Total

stockholders'

equity

Balance, December 31, 2024



162,871,266



$               163



$       964,765



$          (3,666)



$         46,749



$    1,008,011

RSUs and MSUs vested



3,546,776



3









3

Option exercises



42,826





185







185

ESPP purchase



402,822





3,100







3,100

Stock-based compensation







57,005







57,005

Foreign currency translation adjustment









5,206





5,206

Net income











31,446



31,446

Balance, September 30, 2025



166,863,690



$               166



$    1,025,055



$            1,540



$         78,195



$    1,104,956















Three Months Ended September 30, 2024

 

















Common Stock

















(IN THOUSANDS, EXCEPT SHARES)



Shares



Amount



Additional

paid-in

capital



Accumulated

other

comprehensive

loss



Retained

earnings



Total

stockholders'

equity

Balance, June 30, 2024



160,786,740



$               161



$       934,194



$          (2,168)



$         15,389



$       947,576

RSUs and MSUs vested



995,796



1









1

ESPP purchase



172,615





1,478







1,478

Stock-based compensation







16,451







16,451

Foreign currency translation adjustment









892





892

Net income











16,089



16,089

Balance, September 30, 2024



161,955,151



$               162



$       952,123



$          (1,276)



$         31,478



$       982,487













Nine Months Ended September 30, 2024

 















Common Stock

















(IN THOUSANDS, EXCEPT SHARES)



Shares



Amount



Additional

paid-in

capital



Accumulated

other

comprehensive

loss



Retained

earnings



Total

stockholders'

equity

Balance, December 31, 2023



158,757,620



$               159



$       901,259



$             (916)



$            8,954



$       909,456

RSUs and MSUs vested



2,827,628



3









3

Option exercises



44,049





313







313

ESPP purchase



325,854





3,373







3,373

Stock-based compensation







47,178







47,178

Foreign currency translation adjustment









(360)





(360)

Net income











22,524



22,524

Balance, September 30, 2024



161,955,151



$               162



$       952,123



$          (1,276)



$         31,478



$       982,487

 

INTEGRAL AD SCIENCE HOLDING CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)  







Nine Months Ended September 30,

(IN THOUSANDS)



2025



2024

Cash flows from operating activities:









Net income



$            31,446



$            22,524

Adjustments to reconcile net income to net cash provided by operating activities:









Depreciation and amortization



51,605



47,032

Stock-based compensation



56,994



47,185

Foreign currency gain, net



(7,723)



(1,775)

Deferred tax provision (benefit)



5,109



(15,457)

Amortization of debt issuance costs



355



348

(Reversal of) allowance for credit losses



(2,119)



949

Impairment of assets



48



37

Changes in operating assets and liabilities:









Decrease (increase) in accounts receivable



4,464



(7,028)

Decrease (increase) in unbilled receivables



186



(1,723)

Increase in prepaid expenses and other current assets



(14,799)



(18,668)

Increase in operating leases, net



(1,544)



(1,169)

Increase in other long-term assets



(1,201)



(696)

Decrease in accounts payable and accrued expenses and other long-term liabilities



(13,878)



(21,958)

Increase in deferred revenue



768



768

Increase (decrease) in due to/from related party



8



(119)

Net cash provided by operating activities



109,719



50,250

Cash flows from investing activities:









Purchase of property and equipment



(863)



(1,594)

Acquisition and development of internal use software and other



(32,218)



(28,868)

Net cash used in investing activities



(33,081)



(30,462)

Cash flows from financing activities:









Repayment of long-term debt



(35,000)



(90,000)

Payments for debt issuance costs



(1,845)



Proceeds from exercise of stock options



185



313

Cash received from Employee Stock Purchase Program



2,263



2,329

Net cash used in financing activities



(34,397)



(87,358)

Net increase (decrease) in cash, cash equivalents, and restricted cash



42,241



(67,570)

Effect of exchange rate changes on cash, cash equivalents and restricted cash



2,364



(113)

Cash, cash equivalents and restricted cash at beginning of period



87,335



127,290

Cash, cash equivalents, and restricted cash at end of period



$          131,940



$            59,607

Supplemental Disclosures:









Net cash (received) paid during the period for:









Interest



$             (1,015)



$              4,613

Taxes



$            16,860



$            29,942

Non-cash investing and financing activities:









Property and equipment acquired included in accounts payable



$                     5



$                   47

Internal use software acquired included in accounts payable



$                 599



$                 966

Lease liabilities arising from right-of-use assets



$            10,994



$              6,110

 

Supplemental Disclosure Regarding Non-GAAP Financial Information

We use supplemental measures of our performance, which are derived from our consolidated financial information, but which are not presented in our consolidated financial statements prepared in accordance with GAAP. Adjusted EBITDA is the primary financial performance measure used by management to evaluate our business and monitor ongoing results of operations. Adjusted EBITDA is defined as income before depreciation and amortization, stock-based compensation, interest (income) expense, income taxes, acquisition, restructuring and integration costs, foreign exchange loss (gain), net, asset impairments, and other one-time, non-recurring costs. Adjusted EBITDA margin represents the adjusted EBITDA for the applicable period divided by the revenue for that period presented in accordance with GAAP.

We use non-GAAP financial measures to supplement financial information presented on a GAAP basis. We believe that excluding certain items from our GAAP results allows management to better understand our consolidated financial performance from period to period and better project our future consolidated financial performance as forecasts are developed at a level of detail different from that used to prepare GAAP-based financial measures. Moreover, we believe these non-GAAP financial measures provide our shareholders with useful information to help them evaluate our operating results by facilitating an enhanced understanding of our operating performance and enabling them to make more meaningful period-to-period comparisons. Although we believe these measures are useful to investors and analysts for the same reasons they are useful to management, as discussed below, these measures are not a substitute for, or superior to, U.S. GAAP financial measures or disclosures. Our non-GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Reconciliations of historical adjusted EBITDA to its most directly comparable GAAP financial measure, net income/loss, are presented below. We encourage you to review the reconciliations in conjunction with the presentation of the non-GAAP financial measures for each of the periods presented. In future fiscal periods, we may exclude such items and may incur income and expenses similar to these excluded items.

Reconciliation of Adjusted EBITDA

 





Three Months Ended

September 30,



Nine Months Ended

September 30,

(IN THOUSANDS, EXCEPT PERCENTAGES)



2025



2024



2025



2024

Net income



$         7,045



$       16,089



$       31,446



$      22,524

Depreciation and amortization



17,900



16,243



51,605



47,032

Stock-based compensation



22,625



16,443



56,994



47,185

Interest (income) expense, net



(595)



1,325



(680)



4,787

Provision for income taxes



1,124



2,773



9,211



7,562

Acquisition, restructuring and integration costs



411



290



760



1,465

Foreign exchange loss (gain), net



667



(2,607)



(7,113)



(723)

Merger related costs



6,093





6,093



Asset impairments and other costs





90



48



90

Adjusted EBITDA



$       55,270



$       50,646



$     148,364



$    129,922

Revenue



$     154,358



$     133,528



$     437,628



$    377,063

Net income margin



5 %



12 %



7 %



6 %

Adjusted EBITDA margin



36 %



38 %



34 %



34 %

 

About Integral Ad Science

Integral Ad Science (IAS) is a leading global media measurement and optimization platform that delivers the industry's most actionable data to drive superior results for the world's largest advertisers, publishers, and media platforms. IAS's software provides comprehensive and enriched data that ensures ads are seen by real people in safe and suitable environments, while improving return on ad spend for advertisers and yield for publishers. Our mission is to be the global benchmark for trust and transparency in digital media quality. For more information, visit integralads.com.

Forward-Looking Statements

This earnings press release contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this press release are forward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance, including guidance, and business, including pipeline and industry trends. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as "anticipate," "estimate," "expect," "project," "plan," "intend," "believe," "may," "will," "should," "can have," "likely," and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our current expectations relating to the acquisition of the company by Novacap (the "Merger") and the transactions contemplated by the related Merger Agreement, our estimated and projected costs, profitability, expenditures, cash flows, growth rates and financial results or our plans and objectives for future operations, growth initiatives or strategies are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including: (i) the risk that the Merger may not be completed in a timely manner or at all, which may adversely affect our business and the price of our common stock; (ii) the timing to consummate the Merger, or the occurrence of any event, change, or other circumstances that could give rise to the termination of the Merger Agreement, including circumstances requiring a party to pay the other party a termination fee pursuant to the Merger Agreement; (iii) the failure to satisfy the conditions to the consummation of the Merger, and the other transactions contemplated thereby; (iv) the risk that a governmental or regulatory approval that may be required for the Merger is not obtained or is obtained subject to conditions that are not anticipated; (v) the effect of the pendency of the Merger on our business relationships, operating results and business generally; (vi) certain restrictions during the pendency of the Merger that may impact our ability to pursue certain business opportunities or strategic transactions; (vii) risks that the Merger disrupts current plans and operations; (viii) risks related to diverting management's attention from our ongoing business operations; (ix) the outcome of any legal proceedings that may be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto; (x) our ability to retain, hire and integrate skilled personnel, and maintain relationships with key business partners and customers, and others with whom we do business, in light of the proposed Merger; (xi) unexpected costs, charges or expenses resulting from the Merger; (xii) the adverse effect on our business, operating results, financial condition, and prospects from various macroeconomic factors, including instability in geopolitical or market conditions; (xiii) our failure to innovate or make the right investment decisions; (xiv) our ability to provide digital or cross-platform analytics; (xv) our failure to maintain or achieve industry accreditation standards; (xvi) our dependence on integrations with advertising platforms, demand side providers ("DSPs") and proprietary platforms that we do not control; (xvii) our ability to compete successfully with our current or future competitors in an intensely competitive market; (xviii) our ability to sustain our profitability and revenue growth rate; (xix) our dependence on the overall demand for advertising; and (xx) other factors disclosed in our filings with the SEC. Given these factors, as well as other variables that may affect our operating results, you should not rely on forward-looking statements, assume that past financial performance will be a reliable indicator of future performance, or use historical trends to anticipate results or trends in future periods.

We derive many of our forward-looking statements from our operating budgets and forecasts, which are based on many detailed assumptions. While we believe that our assumptions are reasonable, we caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Additional Information and Where to Find It

This communication is being made in respect of the proposed transaction involving the Company and Novacap. The Company will prepare an information statement for its stockholders, containing the information with respect to the proposed merger specified in Schedule 14C promulgated under the Exchange Act, and describing the proposed transaction. In connection with the proposed transaction, the Company filed with the SEC a preliminary information statement. When completed, a definitive information statement will be mailed to the Company's stockholders. This communication is not a substitute for the information statement, or any other document, that the Company may file with the SEC or send to its stockholders in connection with the proposed transaction.

THE COMPANY'S STOCKHOLDERS ARE URGED TO CAREFULLY READ THE INFORMATION STATEMENT REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION.

The Company's stockholders may obtain free copies of the documents the Company files with the SEC from the SEC's website at www.sec.gov or through the Investor Relations page of the Company's website at https://investors.integralads.com or by contacting the Company's Investor Relations by e-mail at [email protected].

No Offer or Solicitation

No person has commenced soliciting proxies in connection with the proposed transaction referenced in this communication, and this communication is neither an offer to purchase nor a solicitation of an offer to sell securities.

Investor Contact:

Jonathan Schaffer

[email protected]

Media Contact:

Tricia Mifsud

[email protected]

 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/ias-reports-third-quarter-2025-financial-results-302603624.html

SOURCE Integral Ad Science, Inc.

Latest News